3 Covid deaths, 30 new cases in Maha
Mumbai: Maharashtra recorded 30 new cases of COVID-19 on Wednesday and three deaths, including one in Satara and two in Nagpur, according to the state health department.
Since January 1, the state has logged 2,425 cases of the infection and 36 fatalities caused by coronavirus, said officials.
Of the new cases in Maharashtra, eight are from Mumbai, three from the jurisdiction of the Thane Municipal Corporation (TMC), two each from areas under the civic bodies of Navi Mumbai and Kalyan-Dombivali, eight from Pune, five from Nagpur and one each from Kolhapur and Sangli, according to an official statement. Mumbai alone has reported 973 cases of the virus, including 532 in June, since the start of January.
You Can Also Check:
Mumbai AQI
|
Weather in Mumbai
|
Bank Holidays in Mumbai
|
Public Holidays in Mumbai
It said that 35 of the 36 people who succumbed to the viral infection since the beginning of this year had co-morbidities which is a medical condition that coexist alongside a primary diagnosis.
The department has conducted 27,394 COVID-19 tests across the state so far this year, while 2,166 patients have recovered to date.PTI
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Deccan Herald
3 hours ago
- Deccan Herald
Kennedy's vaccine panel breaks norms, plans to review immunisation schedule
Committee chair Dr. Martin Kulldorff - a biostatistician and epidemiologist who publicly criticised Covid-19 lockdowns and was fired from Harvard for refusing to take a Covid-19 vaccine - said the panel will review the total number of vaccines U.S. children and adolescents receive, which he said exceeds those given to children in other developed nations.
Mint
4 hours ago
- Mint
FDA expands warning about rare heart side effect in two leading Covid vaccines
The Food and Drug Administration has mandated that Pfizer and Moderna expand warning labels on their mRNA COVID-19 vaccines (Comirnaty and Spikevax) to highlight a rare risk of myocarditis and pericarditis, which are heart inflammation conditions, primarily in males aged 16–25. The updated labels now cite an incidence rate of 38 cases per million doses in this demographic, up from prior warnings focused on ages 12–17 (Pfizer) and 18–24 (Moderna). For all recipients under 65, the overall risk remains low at nearly 8 cases per million doses. This move follows FDA analysis of 2023–2024 vaccine safety data, including insurance claims and a study showing persistent cardiac MRI abnormalities in some patients five months post-diagnosis. The CDC, however, maintains that such cases are rare, typically resolve quickly, and are less severe than those caused by COVID-19 infection itself. Policy clash and political tensions underpin new warnings The FDA's decision conflicts with prior CDC assessments that found no increased myocarditis risk in vaccine injury databases since 2022. It also aligns with broader efforts by Health Secretary Robert F. Kennedy Jr.'s administration to tighten vaccine oversight. Kennedy recently replaced all 17 CDC advisory panel members with appointees, including anti-vaccine advocates, and FDA Commissioner Marty Makary, a critic of COVID-19 booster mandates, has restricted annual shots to high-risk groups (e.g., senior citizens). Also Read | Nestle says it will remove artificial dyes from US foods by 2026 Critics argue the label expansion overlooks context: Studies confirm COVID-19 infection poses a 16-fold higher myocarditis risk than vaccination, and most post-vaccine cases are mild, resolving with anti-inflammatory treatment. Yale researchers note the inflammation is transient, not autoimmune, allowing full recovery. Expert backlash and global safety perspectives Medical experts condemn the FDA's approach as misleading. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris of the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk," according to a report by AP.
Time of India
6 hours ago
- Time of India
3 Covid deaths, 30 new cases in Maha
Mumbai: Maharashtra recorded 30 new cases of COVID-19 on Wednesday and three deaths, including one in Satara and two in Nagpur, according to the state health department. Since January 1, the state has logged 2,425 cases of the infection and 36 fatalities caused by coronavirus, said officials. Of the new cases in Maharashtra, eight are from Mumbai, three from the jurisdiction of the Thane Municipal Corporation (TMC), two each from areas under the civic bodies of Navi Mumbai and Kalyan-Dombivali, eight from Pune, five from Nagpur and one each from Kolhapur and Sangli, according to an official statement. Mumbai alone has reported 973 cases of the virus, including 532 in June, since the start of January. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai It said that 35 of the 36 people who succumbed to the viral infection since the beginning of this year had co-morbidities which is a medical condition that coexist alongside a primary diagnosis. The department has conducted 27,394 COVID-19 tests across the state so far this year, while 2,166 patients have recovered to
